🧠 AI clinical summary is being generated for this article and will appear shortly.
Source: MHRA · Read original ↗
Following the completion of a safety review and the recommendations of the Commission on Human Medicines (CHM), the IXCHIQ Chikungunya vaccine is no longer indicated for adults over the age of 60 years, and is contraindicate…
This content is sourced from MHRA and reproduced for clinical reference. ClinicalIQ does not alter source content.